Cite
HARVARD Citation
Zheng, F. et al. (n.d.). Evaluation of WO2011045166A1, Fkbp52–tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction. Expert opinion on therapeutic patents. pp. 831-835. [Online].